ZEB2 and infection: Similarly, treatment of HSV-1 infected cells with proteasome inhibitor MG132 added after the onset of the infection was sufficient to stabilize ZEB1, but interestingly not ZEB2, in the presence of HSV-1 expressing either wild type ICP0 or the FXE mutant (Figure 7D).